Approved for In combination with platinum/gemcitabine, to treat adults with recurrent or metastatic non-keratinizing nasopharyngeal carcinoma, or as a single agent after platinum-based chemotherapy and another prior line. 12.1 Mechanism of Action Binding of the PD-1 ligands, PD-L1 and PD-L2, to the PD-1 receptor found on T cells, inhibits T-cell proliferation and cytokine production.…
Loading full data from Know Your Drugs Institute…